Daily Market Reports | Feb 20 2026
This story features AUSTRALIAN CLINICAL LABS LIMITED, and other companies.
For more info SHARE ANALYSIS: ACL
The company is included in ASX300 and ALL-ORDS
An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.
In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.
One key difference is the *Extra* Edition will not be updated daily, but merely “regularly” depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.
Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena’s team of journalists.
Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.
The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.
The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.
COMPANIES DISCUSSED IN THIS ISSUE
Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)
ACL ASK COV CSC FFM HSN JDO KYP PPL QAL SEK SGM SHA SRG SXE SYL TNE
ACL AUSTRALIAN CLINICAL LABS LIMITED
Healthcare services – Overnight Price: $2.20
Canaccord Genuity rates ((ACL)) as Downgrade to Hold from Buy (3) –
Australian Clinical Labs posted first half results that missed Canaccord Genuity’s forecasts. The broker suspects the miss, and the downgrade to FY26 guidance, primarily relate to marginal share losses.
Underlying EBIT guidance has been downgraded by -3.5%, further exacerbated by additional operating expenditure stemming from the FWC review of gender undervaluation.
The pathology demand environment is not strong enough to allow the company’s operating model and strategy to be differentiated from listed competitors and drive a re-rating, in the broker’s opinion.
Rating is downgraded to Hold from Buy. Target is reduced to $2.40 from $3.85.
This report was published on February 17, 2026.
Target price is $2.40 Current Price is $2.20 Difference: $0.2
If ACL meets the Canaccord Genuity target it will return approximately 9% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 10.00 cents and EPS of 17.00 cents.
At the last closing share price the estimated dividend yield is 4.55%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.94.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 11.00 cents and EPS of 18.00 cents.
At the last closing share price the estimated dividend yield is 5.00%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.22.
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
ASK ABACUS STORAGE KING
REITs – Overnight Price: $1.51
Jarden rates ((ASK)) as Downgrade to Overweight from Buy (2) –
After further analysis of Abacus Storage King’s interim results, Jarden lowers its target to $1.60 from $1.65 and maintains an Overweight rating.
A summary of the broker’s initial research follows.
On first inspection, Jarden notes Abacus Storage King’ 1H26 result was slightly softer than expected at the earnings line.
Funds from operations came in at 3.12c versus 3.4c for Jarden and 3.3c consensus, with established portfolio RevPAM growth of 1.5% considered weak relative to portfolio quality, while occupancy eased to 90.5% and WACR to 5.42%.
FY26 distribution guidance was maintained at 6.2c, in line with both Jarden and consensus expectations.
Jarden highlights potential investor focus on funding costs and internalisation progress, amid shifting rate expectations and sector M&A activity.
This report was published on February 17, 2026.
Target price is $1.60 Current Price is $1.51 Difference: $0.09
If ASK meets the Jarden target it will return approximately 6% (excluding dividends, fees and charges).
Current consensus price target is $1.58, suggesting upside of 4.3%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 6.20 cents and EPS of 6.50 cents.
At the last closing share price the estimated dividend yield is 4.11%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 23.23.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 6.5, implying annual growth of -70.5%.
Current consensus DPS estimate is 6.2, implying a prospective dividend yield of 4.1%.
Current consensus EPS estimate suggests the PER is 23.2.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 6.30 cents and EPS of 6.60 cents.
At the last closing share price the estimated dividend yield is 4.17%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 22.88.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 6.8, implying annual growth of 4.6%.
Current consensus DPS estimate is 6.4, implying a prospective dividend yield of 4.2%.
Current consensus EPS estimate suggests the PER is 22.2.
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
COV CLEO DIAGNOSTICS LIMITED
Pharmaceuticals & Biotech/Lifesciences – Overnight Price: $0.59
Petra Capital rates ((COV)) as Buy (1) –
Petra Capital highlights Cleo Diagnostics’ selection of Nasdaq-listed Bio-Techne as manufacturer for its ovarian cancer test kits and the choice of Bio-Techne’s Ella platform as a key de-risking milestone.
The broker notes the platform’s automated, multiplex capability and sub-90-minute turnaround as commercially attractive for pathology labs. Recent regulatory CE-IVD marking for diagnostic device compliance is also expected to support regulatory pathways.
Management expects a binding agreement later this quarter to enable analytical validation and pivotal trial sample testing ahead of an FDA 510(k) submission.
Buy. Target $1.26.
This report was published on February 18, 2026.
Target price is $1.26 Current Price is $0.59 Difference: $0.67
If COV meets the Petra Capital target it will return approximately 114% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Petra Capital forecasts a full year FY26 dividend of 0.00 cents.
Forecast for FY27:
Petra Capital forecasts a full year FY27 dividend of 0.00 cents.
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
CSC CAPSTONE COPPER CORP.
Copper – Overnight Price: $14.12
Moelis rates ((CSC)) as Hold (3) –
Capstone Copper has provided guidance for 2026 with a production range of 200-230,000t of copper at US$2.45-2.75/lb in C1 cash costs. Combined capital will total -US$790m, which compares with Moelis’ previous estimate of -US$415m.
While being forced to materially downgrade its numbers, the broker believes the market has acted impulsively in reaction to the news.
Some valuation support is envisaged returning to the stock, particularly in marking to market spot prices, but the case for aggressive accumulation is not yet there, Moelis asserts.
Ownership at current levels is considered either for longer-term investors or those less concerned about short-term volatility in the metal price. Target is $14.50 and a Hold rating is retained.
This report was published on February 18, 2026.
Target price is $14.50 Current Price is $14.12 Difference: $0.38
If CSC meets the Moelis target it will return approximately 3% (excluding dividends, fees and charges).
Current consensus price target is $15.86, suggesting upside of 12.3%(ex-dividends)
The company’s fiscal year ends in December.
Forecast for FY25:
Moelis forecasts a full year FY25 dividend of 0.00 cents and EPS of 71.04 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 19.88.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 38.2, implying annual growth of 128.2%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 37.0.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 0.00 cents and EPS of 35.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 40.34.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 66.9, implying annual growth of 75.1%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 21.1.
Market Sentiment: 0.9
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
FFM FIREFLY METALS LIMITED
Gold & Silver – Overnight Price: $1.94
Moelis rates ((FFM)) as Buy (1) –
Moelis considers the first half results from FireFly Metals largely immaterial given the business is pre-production. The company has been running an aggressive exploration program and expenditure was higher than anticipated.
The broker lifts exploration expenditure estimates for the next 12 months to $40m to reflect the increased activity and remains constructive on the stock, despite the fact that share price outperformance becomes more difficult as development commences. Buy rating. Target is $2.10.
This report was published on February 17, 2026.
Target price is $2.10 Current Price is $1.94 Difference: $0.16
If FFM meets the Moelis target it will return approximately 8% (excluding dividends, fees and charges).
Current consensus price target is $1.95, suggesting upside of 0.5%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 0.00 cents and EPS of minus 2.70 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 71.85.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is -2.9, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 0.00 cents and EPS of minus 4.60 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is minus 42.17.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is -1.4, implying annual growth of N/A.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is N/A.
Market Sentiment: 0.3
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
HSN HANSEN TECHNOLOGIES LIMITED
IT & Support – Overnight Price: $5.27
Moelis rates ((HSN)) as Buy (1) –
Hansen Technologies produced a “remarkable” margin performance in the first half, Moelis asserts, with EBITDA margins exceeding estimates that were considered optimistic.
The quality of earnings also improved, with reduced capitalisation of development costs and a lower proportion of “lumpy” license sales. Despite currency headwinds, management is guiding to higher sequential revenue in the second half.
While a stronger Australian dollar will weigh on organic growth, margin growth will offset the FX-related revenue headwind in the broker’s opinion. Buy rating. Target is $7.20.
This report was published on February 18, 2026.
Target price is $7.20 Current Price is $5.27 Difference: $1.93
If HSN meets the Moelis target it will return approximately 37% (excluding dividends, fees and charges).
Current consensus price target is $6.95, suggesting upside of 31.8%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 10.00 cents and EPS of 29.90 cents.
At the last closing share price the estimated dividend yield is 1.90%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 17.63.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 27.2, implying annual growth of 27.9%.
Current consensus DPS estimate is 10.0, implying a prospective dividend yield of 1.9%.
Current consensus EPS estimate suggests the PER is 19.4.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 12.00 cents and EPS of 32.80 cents.
At the last closing share price the estimated dividend yield is 2.28%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 16.07.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 31.9, implying annual growth of 17.3%.
Current consensus DPS estimate is 10.0, implying a prospective dividend yield of 1.9%.
Current consensus EPS estimate suggests the PER is 16.5.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
JDO JUDO CAPITAL HOLDINGS LIMITED
Business & Consumer Credit – Overnight Price: $1.82
Jarden rates ((JDO)) as Buy (1) –
Jarden raises its 12-month target price for Judo Capital by 4% to $2.50 and reiterates a Buy rating following interim results.
Cash profit of $60m was in line with the broker’s forecast and up 46% year-on-year, with FY26 guidance reaffirmed. The 2H26 net interest margin (NIM) guidance was raised to around 3.15% from 3.10%.
The broker incrementally raises its earnings forecasts, reflecting improved net interest margin (NIM) guidance and operating leverage.
While CET1 of 12.6% declined by -55bps half-on-half due to loan growth, Jarden expects organic capital generation to strengthen as profitability improves.
FY26 guidance includes loans of $14.2-14.7bn, NIM of 3.0-3.1%, cost-to-income ratio below 50%, and profit of $180-190m in FY26, implying 43-51% growth.
This report was published on February 17, 2026.
Target price is $2.50 Current Price is $1.82 Difference: $0.68
If JDO meets the Jarden target it will return approximately 37% (excluding dividends, fees and charges).
Current consensus price target is $2.19, suggesting upside of 20.3%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 0.00 cents and EPS of 10.80 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 16.85.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 11.7, implying annual growth of 51.0%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 15.6.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 0.00 cents and EPS of 17.10 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 10.64.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 15.4, implying annual growth of 31.6%.
Current consensus DPS estimate is N/A, implying a prospective dividend yield of N/A.
Current consensus EPS estimate suggests the PER is 11.8.
Market Sentiment: 0.9
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
KYP KINATICO LIMITED
Software & Services – Overnight Price: $0.20
Research as a Service (RaaS) rates ((KYP)) as No Rating (-1) –
Kinatico’s 1H FY26 adjusted earnings (EBITDA) of $3.0m represented a 32% on the prior year. This was 4% ahead of Research as a Service (RaaS)’s forecast, driven by higher-margin SaaS revenue, which accounted for 55% of total revenue.
The adjusted earnings margin of 16.9% reflects operating leverage, highlights the analyst. Management pointed to a $10m SaaS pipeline supporting 2H acceleration.
RaaS upgrades its FY26/27/28 earnings forecasts by 5.5%/12%/6%, respectively, citing stronger margins and mix shift benefits.
Despite a higher assumed risk-free rate the analyst’s target remains at $0.45c.
Research as a Service doesn’t carry any ratings or targets. Investors can draw conclusions from valuations and commentary.
This report was published on February 18, 2026.
Target price is $0.45 Current Price is $0.20 Difference: $0.25
If KYP meets the Research as a Service (RaaS) target it will return approximately 125% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Research as a Service (RaaS) forecasts a full year FY26 dividend of 0.00 cents and EPS of 56.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 0.36.
Forecast for FY27:
Research as a Service (RaaS) forecasts a full year FY27 dividend of 0.00 cents and EPS of 109.00 cents.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 0.18.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
PPL PUREPROFILE LIMITED
Overnight Price: $0.04
Research as a Service (RaaS) rates ((PPL)) as No Rating (-1) –
Pureprofile has agreed to acquire Australian qualitative research firm Crnrstone, often styled “Crnrstone Research” for -$0.7m.
Research as a Service (RaaS) expects the deal to contribute around $1m in FY26 revenue and $0.1m in earnings (EBITDA) for the four months to June 30, 2026, and upgrades FY27 forecasts by approximately 5%.
The acquisition is forecast to be EPS accretive by $0.01 per share in both FY26 and FY27.
RaaS lifts its target to $0.12c from $0.11c, implying significant upside to the current share price.
RaaS research updates don’t carry any ratings or targets. Investors can draw conclusions from valuations and commentary.
This report was published on February 18, 2026.
Target price is $0.12 Current Price is $0.04 Difference: $0.08
If PPL meets the Research as a Service (RaaS) target it will return approximately 200% (excluding dividends, fees and charges).
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
QAL QUALITAS LIMITED
Wealth Management & Investments – Overnight Price: $3.25
Canaccord Genuity rates ((QAL)) as Buy (1) –
Qualitas delivered first half revenue and earnings that were ahead of Canaccord Genuity’s estimates. The results absorbed a small loss in Arch finance which for the broker highlights the strong performance in the core business.
Guidance for FY26 has been maintained for pre-tax profit at $60-66m and, while acknowledging there needs to be continued effort to meet this, Canaccord Genuity believes the company is strongly positioned going into FY27.
The stock offers an attractive entry price to a multi-year growth story, having established itself as one of the premier operators in the asset class, Canaccord Genuity states.
The broker retains a Buy rating, raising the target to $4.40 from $4.25.
This report was published on February 17, 2026.
Target price is $4.40 Current Price is $3.25 Difference: $1.15
If QAL meets the Canaccord Genuity target it will return approximately 35% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 13.00 cents and EPS of 15.00 cents.
At the last closing share price the estimated dividend yield is 4.00%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 21.67.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 16.00 cents and EPS of 18.00 cents.
At the last closing share price the estimated dividend yield is 4.92%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 18.06.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
SEK SEEK LIMITED
Jobs & Skilled Labour Services – Overnight Price: $16.45
Jarden rates ((SEK)) as Buy (1) –
Jarden lowers its target price on Seek by -16% to $25.00 and retains a Buy rating following an in-line interim result. Management made a small upgrade to its FY26 earnings/free cash flow (FCF) guidance.
Interim revenue rose 12% to $601m and earnings increased 19% to $267m, with A&NZ yield growth of 17% the key highlight for the analysts.
The broker trims its FY26 profit estimate by -5% to $198m, near the bottom of guidance, reflecting higher net interest and share-based payment expenses.
The target reduction reflects a higher weighted average cost of capital (WACC), a larger discount to the Growth Fund valuation, and a Zhaopin write down, explain the analysts. Solid underlying execution provided some offset, notes Jarden.
This report was published on February 18, 2026.
Target price is $25.00 Current Price is $16.45 Difference: $8.55
If SEK meets the Jarden target it will return approximately 52% (excluding dividends, fees and charges).
Current consensus price target is $25.74, suggesting upside of 56.5%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 51.20 cents and EPS of 55.30 cents.
At the last closing share price the estimated dividend yield is 3.11%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 29.75.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 56.3, implying annual growth of -18.1%.
Current consensus DPS estimate is 54.3, implying a prospective dividend yield of 3.3%.
Current consensus EPS estimate suggests the PER is 29.2.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 66.70 cents and EPS of 69.90 cents.
At the last closing share price the estimated dividend yield is 4.05%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 23.53.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 71.6, implying annual growth of 27.2%.
Current consensus DPS estimate is 65.0, implying a prospective dividend yield of 4.0%.
Current consensus EPS estimate suggests the PER is 23.0.
Market Sentiment: 0.9
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
SGM SIMS LIMITED
Steel & Scrap – Overnight Price: $21.77
Jarden rates ((SGM)) as Underweight (4) –
The analysts at Jarden raise their target price for Sims to $19.50 from $18.50 following a 16% 1H26 earnings (EBIT) ‘beat’ compared to the consensus forecast.
The metals businesses outperformed guidance, while Sims Lifecycle Services (SLS) delivered $49m of earnings, at the top end of prior guidance. This outcome was supported by favourable dynamic random access memory (DRAM) pricing, highlights Jarden.
The broker forecasts 2H SLS earnings of $64m, implying 30% sequential growth, but notes limited guidance has heightened market uncertainty. The Underweight rating is maintained.
This report was published on February 17, 2026.
Target price is $19.50 Current Price is $21.77 Difference: minus $2.27 (current price is over target).
If SGM meets the Jarden target it will return approximately minus 10% (excluding dividends, fees and charges – negative figures indicate an expected loss).
Current consensus price target is $18.56, suggesting downside of -14.7%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 28.00 cents and EPS of 76.10 cents.
At the last closing share price the estimated dividend yield is 1.29%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 28.61.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 79.7, implying annual growth of N/A.
Current consensus DPS estimate is 32.5, implying a prospective dividend yield of 1.5%.
Current consensus EPS estimate suggests the PER is 27.3.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 37.00 cents and EPS of 102.80 cents.
At the last closing share price the estimated dividend yield is 1.70%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 21.18.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 115.9, implying annual growth of 45.4%.
Current consensus DPS estimate is 40.3, implying a prospective dividend yield of 1.9%.
Current consensus EPS estimate suggests the PER is 18.8.
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
SHA SHAPE AUSTRALIA CORPORATION LIMITED
Industrial Sector Contractors & Engineers – Overnight Price: $7.59
Moelis rates ((SHA)) as Buy (1) –
Shape Australia’s first half results beat estimates with a record backlog of orders totalling $686.1m, which increases the near-term revenue visibility, Moelis notes.
Commentary posits the results demonstrate the business mix shifting towards a more diversified contractor and services platform with higher value work and a growing share of non-commercial office end markets.
The broker upgrades FY26 and FY27 estimates for EPS to 35.5 cents and 39.8 cents, respectively. Buy. Target is $8.25.
This report was published on February 19, 2026.
Target price is $8.25 Current Price is $7.59 Difference: $0.66
If SHA meets the Moelis target it will return approximately 9% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 30.70 cents and EPS of 35.50 cents.
At the last closing share price the estimated dividend yield is 4.04%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 21.38.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 34.40 cents and EPS of 39.80 cents.
At the last closing share price the estimated dividend yield is 4.53%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 19.07.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
SRG SRG GLOBAL LIMITED
Mining Sector Contracting – Overnight Price: $2.88
Moelis rates ((SRG)) as Buy (1) –
SRG Global produced a “solid” first half result with net profit that was ahead of Moelis estimates. FY26 guidance has been upgraded, with EBITDA now expected in a range of $164-168m.
The broker notes significant work in hand with a strong recurring component and this should support growth. Modest upgrades to estimates are made and a Buy rating is maintained. Target is $3.15.
This report was published on February 18, 2026.
Target price is $3.15 Current Price is $2.88 Difference: $0.27
If SRG meets the Moelis target it will return approximately 9% (excluding dividends, fees and charges).
Current consensus price target is $3.18, suggesting upside of 10.2%(ex-dividends)
The company’s fiscal year ends in June.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 6.70 cents and EPS of 11.40 cents.
At the last closing share price the estimated dividend yield is 2.33%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 25.26.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 13.0, implying annual growth of 61.7%.
Current consensus DPS estimate is 6.5, implying a prospective dividend yield of 2.3%.
Current consensus EPS estimate suggests the PER is 22.2.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 8.60 cents and EPS of 13.70 cents.
At the last closing share price the estimated dividend yield is 2.99%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 21.02.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 14.8, implying annual growth of 13.8%.
Current consensus DPS estimate is 7.0, implying a prospective dividend yield of 2.4%.
Current consensus EPS estimate suggests the PER is 19.5.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
SXE SOUTHERN CROSS ELECTRICAL ENGINEERING LIMITED
Mining Sector Contracting – Overnight Price: $3.45
Moelis rates ((SXE)) as Buy (1) –
Southern Cross Electrical Engineering has upgraded FY26 guidance to at least $72m in EBITDA and Moelis notes a strong order book is near record highs.
The broker expects data centre work in particular will underpin the near-term outlook and is encouraged by the company’s expectations for further growth beyond FY26.
Strong structural tailwinds and electrification and decarbonisation are translating into data centre and infrastructure expenditure.
The balance sheet is strong, debt free and there is acquisition firepower, the broker adds, in spite of an adverse WestConnex settlement.
Buy rating. Target is increased to $3.73.
This report was published on February 19, 2026.
Target price is $3.73 Current Price is $3.45 Difference: $0.28
If SXE meets the Moelis target it will return approximately 8% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 8.00 cents and EPS of 15.70 cents.
At the last closing share price the estimated dividend yield is 2.32%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 21.97.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 8.00 cents and EPS of 16.60 cents.
At the last closing share price the estimated dividend yield is 2.32%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 20.78.
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
SYL SYMAL GROUP LIMITED
Industrial Sector Contractors & Engineers – Overnight Price: $3.18
Jarden rates ((SYL)) as Buy (1) –
Ahead of interim results, Jarden raises its target price on Symal Group to $3.45 from $2.70. This jump largely reflects adjustments to the broker’s valuation framework. A Buy rating is retained.
The broker forecasts underlying earnings (EBITDA) of $51.4m, up 5.5%, with earnings skewed to 2H. It’s anticipated FY26 EBITDA will be around $126m, near the top of $117-$127m guidance.
The analysts are looking for stronger Contracting Services margins, cash conversion above 100% and clarity on recent M&A contributions.
This report was published on February 17, 2026.
Target price is $3.45 Current Price is $3.18 Difference: $0.27
If SYL meets the Jarden target it will return approximately 8% (excluding dividends, fees and charges).
The company’s fiscal year ends in June.
Forecast for FY26:
Jarden forecasts a full year FY26 dividend of 12.20 cents and EPS of 24.60 cents.
At the last closing share price the estimated dividend yield is 3.84%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 12.93.
Forecast for FY27:
Jarden forecasts a full year FY27 dividend of 14.80 cents and EPS of 29.40 cents.
At the last closing share price the estimated dividend yield is 4.65%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 10.82.
Market Sentiment: 0.8
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
TNE TECHNOLOGY ONE LIMITED
IT & Support – Overnight Price: $24.69
Canaccord Genuity rates ((TNE)) as Buy (1) –
TechnologyOne provided formal FY26 guidance at its AGM update, flagging annual recurring revenue of $643-654m and pre-tax profit of $214.2-217.9m.
The company is targeting the top end of both metrics, which Canaccord Genuity notes have FX implications from a stronger AUD/GBP factored in.
The company has also flagged the front loading of costs surrounding the showcase in both Australia and the UK that will limit first half profit growth but should deliver a meaningful acceleration in the second half.
With multi-year contracts and a strong brand, Canaccord Genuity believes the business is well insulated and retains a Buy rating with a $42.15 target.
This report was published on February 18, 2026.
Target price is $42.15 Current Price is $24.69 Difference: $17.46
If TNE meets the Canaccord Genuity target it will return approximately 71% (excluding dividends, fees and charges).
Current consensus price target is $33.04, suggesting upside of 33.8%(ex-dividends)
The company’s fiscal year ends in September.
Forecast for FY26:
Canaccord Genuity forecasts a full year FY26 dividend of 344.00 cents and EPS of 50.00 cents.
At the last closing share price the estimated dividend yield is 13.93%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 49.38.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 49.3, implying annual growth of 17.0%.
Current consensus DPS estimate is 33.5, implying a prospective dividend yield of 1.4%.
Current consensus EPS estimate suggests the PER is 50.1.
Forecast for FY27:
Canaccord Genuity forecasts a full year FY27 dividend of 42.00 cents and EPS of 60.00 cents.
At the last closing share price the estimated dividend yield is 1.70%.
At the last closing share price the stock’s estimated Price to Earnings Ratio (PER) is 41.15.How do these forecasts compare to market consensus projections?
Current consensus EPS estimate is 58.5, implying annual growth of 18.7%.
Current consensus DPS estimate is 39.3, implying a prospective dividend yield of 1.6%.
Current consensus EPS estimate suggests the PER is 42.2.
Market Sentiment: 0.9
All consensus data are updated until yesterday. FNArena’s consensus calculations require a minimum of three sources
Disclaimer:
The content of this information does in no way reflect the opinions of FNArena, or of its journalists. In fact we don’t have any opinion about the stock market, its value, future direction or individual shares. FNArena solely reports about what the main experts in the market note, believe and comment on. By doing so we believe we provide experienced, intelligent investors with a valuable tool that helps them in making up their own minds, reading market trends and getting a feel for what is happening beneath the surface.
This document is provided for informational purposes only. It does not constitute an offer to sell or a solicitation to buy any security or other financial instrument. FNArena employs very experienced journalists who base their work on information believed to be reliable and accurate, though no guarantee is given that the daily report is accurate or complete. Investors should contact their personal adviser before making any investment decision.
<span style="
Click to view our Glossary of Financial Terms
CHARTS
For more info SHARE ANALYSIS: ACL - AUSTRALIAN CLINICAL LABS LIMITED
For more info SHARE ANALYSIS: ASK - ABACUS STORAGE KING
For more info SHARE ANALYSIS: COV - CLEO DIAGNOSTICS LIMITED
For more info SHARE ANALYSIS: CSC - CAPSTONE COPPER CORP.
For more info SHARE ANALYSIS: FFM - FIREFLY METALS LIMITED
For more info SHARE ANALYSIS: HSN - HANSEN TECHNOLOGIES LIMITED
For more info SHARE ANALYSIS: JDO - JUDO CAPITAL HOLDINGS LIMITED
For more info SHARE ANALYSIS: KYP - KINATICO LIMITED
For more info SHARE ANALYSIS: PPL - PUREPROFILE LIMITED
For more info SHARE ANALYSIS: QAL - QUALITAS LIMITED
For more info SHARE ANALYSIS: SEK - SEEK LIMITED
For more info SHARE ANALYSIS: SGM - SIMS LIMITED
For more info SHARE ANALYSIS: SHA - SHAPE AUSTRALIA CORPORATION LIMITED
For more info SHARE ANALYSIS: SRG - SRG GLOBAL LIMITED
For more info SHARE ANALYSIS: SXE - SOUTHERN CROSS ELECTRICAL ENGINEERING LIMITED
For more info SHARE ANALYSIS: SYL - SYMAL GROUP LIMITED
For more info SHARE ANALYSIS: TNE - TECHNOLOGY ONE LIMITED